Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Treatment intensity in older adults with AML: Impact of age and induction regimen on remission and survival outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

YAYzen AlmarrawiAMAndrew A. Muskovitz

Discussion

Loading...

Member takes

Overview

Retrospective cohort study reveals induction therapy impacts remission and elderly survival in adults with acute myeloid leukemia, highlighting personalized treatment needs.

Key Points

  • Older adults with acute myeloid leukemia showed improved remission rates with intensive therapy compared to lower intensity regimens.
  • In patients over 60, those receiving Anthracycline+Cytarabine achieved a remission rate of 68.97%.
  • Analysis utilized multivariable regression to assess patient outcomes based on induction regimen and cytogenetic risk.
  • Findings underscore the importance of molecular profiling and patient selection in treatment strategy for acute myeloid leukemia.

Cite This Study

Almarrawi et al. (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e5b8https://doi.org/10.1182/blood-2025-6907
View Full Paper
Ask AI
Bookmark
Share